Berit Nicolaisen

Berit Nicolaisen is an accomplished clinical trial manager with extensive experience in the pharmaceutical and biotechnology sectors. Currently at Vaccibody AS since June 2019, Berit has previously served as a project manager at Lytix Biopharma, leading the development of the oncolytic peptide LTX-315. Prior to that, at Photocure ASA, Berit held the position of project director, overseeing a new product development in photodynamic diagnostics and managing a successful partnership with Salix Pharmaceutical Inc. Berit's career at Pfizer spanned from 1992 to 2007, including roles such as business support manager, senior international project manager, therapeutic unit manager, and clinical research manager. Early career experience at Weifa AS also involved responsibilities in clinical and regulatory affairs. Academic qualifications include an M.Sc. in Physiology from the University of Oslo and multiple executive education programs at BI Norwegian Business School and INSEAD.